Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) shares, rose in value on Wednesday, April 16, with the stock price down by -0.58% to the previous day’s close as strong demand from buyers drove the stock to $1.72.
Actively observing the price movement in the last trading, the stock closed the session at $1.73, falling within a range of $1.7 and $1.785. The value of beta (5-year monthly) was 0.179. Referring to stock’s 52-week performance, its high was $11.56, and the low was $1.68. On the whole, MRVI has fluctuated by -33.33% over the past month.
With the market capitalization of Maravai LifeSciences Holdings Inc currently standing at about $437.46 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-17.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRVI’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MRVI currently trading nearly -17.20% and -40.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 26.10, while the 7-day volatility ratio is showing 7.06% which for the 30-day chart, stands at 9.31%. Furthermore, Maravai LifeSciences Holdings Inc (MRVI)’s beta value is 0.26, and its average true range (ATR) is 0.20.
A comparison of Maravai LifeSciences Holdings Inc (MRVI) with its peers suggests the former has fared considerably weaker in the market. MRVI showed an intraday change of -0.58% in last session, and over the past year, it shrunk by -78.79%%.
Data on historical trading for Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) indicates that the trading volumes over the past 10 days have averaged 2.56 and over the past 3 months, they’ve averaged 3.37 million. According to company’s latest data on outstanding shares, there are 141.98 million shares outstanding.
Nearly 18.71% of Maravai LifeSciences Holdings Inc’s shares belong to company insiders and institutional investors own 85.98% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.13 million shares as on 2025-03-31, resulting in a short ratio of 3.37. According to the data, the short interest in Maravai LifeSciences Holdings Inc (MRVI) stood at 1088.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 8.82 million. The stock has fallen by -68.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRVI stock heading into the next quarter.
